• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过单颗粒示踪技术监测活细胞中适配体-药物偶联物的内吞途径和细胞内运输。

Endocytic Pathways and Intracellular Transport of Aptamer-Drug Conjugates in Live Cells Monitored by Single-Particle Tracking.

机构信息

Institute of Molecular Medicine (IMM), State Key Laboratory of Oncogenes and Related Genes Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering , Shanghai Jiao Tong University , Shanghai 200240 , China.

Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Province , Hunan University , Changsha , Hunan 410082 , China.

出版信息

Anal Chem. 2019 Nov 5;91(21):13818-13823. doi: 10.1021/acs.analchem.9b03281. Epub 2019 Oct 24.

DOI:10.1021/acs.analchem.9b03281
PMID:31593429
Abstract

Aptamer-drug conjugates (ApDCs) are emerging as targeted therapeutic drugs that can effectively broaden the chemotherapeutic window with higher efficacy and less toxicity. They show promising targeted tumor-killing effects both and . However, the mechanisms underlying the cellular internalization and transport of ApDCs remain unclear, and no systematic study on this topic has been reported. Therefore, we herein investigated the endocytic internalization and subsequent transport of ApDCs in mammalian cells through single-particle tracking. We found that ApDC enters the cells mainly by caveolin-mediated endocytosis and that it exhibits cytoskeleton-dependent transport, along microfilaments and microtubules, to acidic endosomes near the cell nucleus in cytoplasm. We also found that the cellular uptake pathways of ApDCs are identical to those of the aptamer itself, confirming that aptamers play a prominent role in the internalization of ApDCs. This study extends our understanding of the internalization and transport process of ApDCs such that the results could serve as the theoretical foundation for designing new ApDCs and, in turn, promoting cancer-targeted therapy.

摘要

适体-药物偶联物(ApDCs)作为靶向治疗药物正在兴起,它们可以通过提高疗效和降低毒性来有效拓宽化疗窗口。它们在体内和体外都表现出有前途的靶向肿瘤杀伤作用。然而,ApDC 进入细胞的细胞内化和运输机制仍不清楚,也没有对此主题的系统研究。因此,我们通过单颗粒示踪法研究了 ApDC 在哺乳动物细胞中的内吞作用和随后的运输。我们发现 ApDC 主要通过网格蛋白介导的内吞作用进入细胞,并且沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管沿着微丝和微管进入细胞。我们还发现,ApDC 的细胞摄取途径与适体本身的摄取途径相同,这证实了适体在 ApDC 的内化中起重要作用。这项研究扩展了我们对 ApDC 内化和运输过程的理解,为设计新型 ApDC 提供了理论基础,并进而促进了癌症靶向治疗。

相似文献

1
Endocytic Pathways and Intracellular Transport of Aptamer-Drug Conjugates in Live Cells Monitored by Single-Particle Tracking.通过单颗粒示踪技术监测活细胞中适配体-药物偶联物的内吞途径和细胞内运输。
Anal Chem. 2019 Nov 5;91(21):13818-13823. doi: 10.1021/acs.analchem.9b03281. Epub 2019 Oct 24.
2
A basic insight into aptamer-drug conjugates (ApDCs).对适体药物偶联物(ApDCs)的基本了解。
Biomaterials. 2018 Nov;182:216-226. doi: 10.1016/j.biomaterials.2018.08.021. Epub 2018 Aug 8.
3
Systemic delivery of aptamer-drug conjugates for cancer therapy using enzymatically generated self-assembled DNA nanoparticles.使用酶促生成的自组装DNA纳米颗粒进行适体-药物偶联物的全身递送用于癌症治疗。
Nanoscale. 2020 Nov 26;12(45):22945-22951. doi: 10.1039/d0nr05652a.
4
Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy.用于靶向癌症治疗的适配体-药物偶联物的设计与临床进展。
Biomater Res. 2021 Nov 25;25(1):42. doi: 10.1186/s40824-021-00244-4.
5
Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers.适体核苷酸类似物药物偶联物在癌症靶向治疗中的应用
Front Cell Dev Biol. 2022 Dec 5;10:1053984. doi: 10.3389/fcell.2022.1053984. eCollection 2022.
6
Automated modular synthesis of aptamer-drug conjugates for targeted drug delivery.用于靶向药物递送的适配体-药物偶联物的自动化模块化合成。
J Am Chem Soc. 2014 Feb 19;136(7):2731-4. doi: 10.1021/ja4117395. Epub 2014 Feb 7.
7
Polymeric Engineering of Aptamer-Drug Conjugates for Targeted Cancer Therapy.适体-药物偶联物的聚合工程用于靶向癌症治疗。
Bioconjug Chem. 2020 Jan 15;31(1):37-42. doi: 10.1021/acs.bioconjchem.9b00715. Epub 2019 Dec 16.
8
An exploration of aptamer internalization mechanisms and their applications in drug delivery.适体内化机制及其在药物传递中的应用研究。
Expert Opin Drug Deliv. 2019 Mar;16(3):207-218. doi: 10.1080/17425247.2019.1575808. Epub 2019 Feb 6.
9
Bifunctional G-Quadruplex Aptamer Targeting Nucleolin and Topoisomerase 1: Antiproliferative Activity and Synergistic Effect of Conjugated Drugs.双功能 G-四链体适体靶向核仁素和拓扑异构酶 1:共轭药物的抗增殖活性和协同作用。
Bioconjug Chem. 2023 Jan 18;34(1):238-247. doi: 10.1021/acs.bioconjchem.2c00540. Epub 2022 Dec 14.
10
Dissecting the Cell Entry Pathway of Baculovirus by Single-Particle Tracking and Quantitative Electron Microscopic Analysis.通过单颗粒跟踪和定量电子显微镜分析剖析杆状病毒的细胞进入途径。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.00033-19. Print 2019 Apr 15.

引用本文的文献

1
Aptamer-ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy.适体-寡核苷酸嵌合体:实现细胞特异性寡核苷酸靶向治疗。
Cells. 2025 May 12;14(10):697. doi: 10.3390/cells14100697.
2
Screening and Identification of Novel DNA Aptamer for Targeted Delivery to Injured Podocytes in Glomerular Diseases.用于靶向递送至肾小球疾病中损伤足细胞的新型DNA适配体的筛选与鉴定
Adv Sci (Weinh). 2025 May;12(20):e2412356. doi: 10.1002/advs.202412356. Epub 2025 Apr 3.
3
Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines.
探讨基于阿霉素的离子型纳米药物中内吞作用途径和细胞器运输的作用。
ACS Appl Bio Mater. 2024 Aug 19;7(8):5359-5368. doi: 10.1021/acsabm.4c00552. Epub 2024 Aug 5.
4
Intracellular transport dynamics revealed by single-particle tracking.单粒子追踪揭示的细胞内运输动力学
Biophys Rep. 2021 Oct 31;7(5):413-427. doi: 10.52601/bpr.2021.210035.
5
Recent progress of aptamer‒drug conjugates in cancer therapy.适体-药物偶联物在癌症治疗中的最新进展。
Acta Pharm Sin B. 2023 Apr;13(4):1358-1370. doi: 10.1016/j.apsb.2023.01.017. Epub 2023 Jan 26.
6
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems.改善抗癌药物治疗的功能配体:现状和在药物传递系统中的应用。
Drug Deliv. 2022 Dec;29(1):1959-1970. doi: 10.1080/10717544.2022.2089296.
7
Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer.非小细胞肺癌中表皮生长因子受体酪氨酸激酶抑制剂耐药性的荧光成像
Cancers (Basel). 2022 Jan 28;14(3):686. doi: 10.3390/cancers14030686.
8
Target-responsive subcellular catabolism analysis for early-stage antibody-drug conjugates screening and assessment.用于早期抗体药物偶联物筛选和评估的靶向响应性亚细胞分解代谢分析
Acta Pharm Sin B. 2021 Dec;11(12):4020-4031. doi: 10.1016/j.apsb.2021.05.024. Epub 2021 May 27.
9
Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents.用于作为药物制剂的细胞内化核酸适配体的摄取机制。
RSC Med Chem. 2021 Jul 24;12(10):1640-1649. doi: 10.1039/d1md00199j. eCollection 2021 Oct 20.
10
A GD2-aptamer-mediated, self-assembling nanomedicine for targeted multiple treatments in neuroblastoma theranostics.一种用于神经母细胞瘤诊疗中靶向多种治疗的GD2适配体介导的自组装纳米药物。
Mol Ther Nucleic Acids. 2021 Aug 26;26:732-748. doi: 10.1016/j.omtn.2021.08.021. eCollection 2021 Dec 3.